Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Adrianus C M Boon
Affiliation
ORCID
Career Start Year
2000
Papers
98
H Index
38
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37223945
The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.
J Virol
2023
36375268
Prevalence of Bourbon and Heartland viruses in field collected ticks at an environmental field station in St. Louis County, Missouri, USA.
Ticks and Tick-borne Diseases
2023
37676002
Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.
J Virol
2023
38076895
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates.
2023
37402814
An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo.
Nat Commun
2023
37205450
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters.
2023
37205409
Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron Variants in Mice and Hamsters.
bioRxiv
2023
36700653
Virology under the Microscope-a Call for Rational Discourse.
mSphere
2023
36700642
Virology under the Microscope-a Call for Rational Discourse.
mBio
2023
36700640
Virology under the Microscope-a Call for Rational Discourse.
J Virol
2023
36695597
mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19.
2023
36993345
The highly conserved stem-loop II motif is dispensable for SARS-CoV-2.
bioRxiv
2023
37429842
Real-time environmental surveillance of SARS-CoV-2 aerosols.
2023
37498298
Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care.
2023
35169798
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques.
2022
35523141
Stem-cell-derived trophoblast organoids model human placental development and susceptibility to emerging pathogens.
2022
35584653
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.
Med
2022
36004663
COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis.
Brain
2022
35427477
Vaccine protection against the SARS-CoV-2 Omicron variant in macaques.
Cell
2022
35676404
Estrogen hormone is an essential sex factor inhibiting inflammation and immune response in COVID-19.
Sci Rep
2022
35547847
The highly conserved stem-loop II motif is important for the lifecycle of astroviruses but dispensable for SARS-CoV-2.
bioRxiv
2022
35607948
Detection of Bourbon Virus-Specific Serum Neutralizing Antibodies in Human Serum in Missouri, USA.
mSphere
2022
35720389
Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.
Frontiers in Immunology
2022
36459536
Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters.
PLoS Pathog
2022
34794169
Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.
Nature
2022
34481543
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.
Immunity
2021
33907753
A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope.
bioRxiv
2021
33691139
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
Cell
2021
33791696
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants.
bioRxiv
2021
34153975
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
Nature
2021
33664494
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.
Nat Med
2021
34245672
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Cell Rep
2021
33594356
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies.
Res Sq
2021
34632326
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro.
iScience
2021
34464596
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.
Immunity
2021
34517754
Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
mBio
2021
34981044
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters.
Res Sq
2021
34729556
COVID-19 induces neuroinflammation and loss of hippocampal neurogenesis.
Res Sq
2021
34611658
Estrogen Hormone Is an Essential Sex Factor Inhibiting Inflammation and Immune Response in COVID-19.
Res Sq
2021
33398272
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection.
bioRxiv
2020
32878932
A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture.
mSphere
2020
32699843
An Agonistic Anti-CD137 Antibody Disrupts Lymphoid Follicle Structure and T-Cell-Dependent Antibody Responses.
Cell Rep Med
2020
33299991
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
bioRxiv
2020
32637945
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities.
2020
32511543
Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease.
medRxiv
2020
32839537
Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs.
Nat Microbiol
2020
31194854
Therapeutic efficacy of favipiravir against Bourbon virus in mice.
PLoS Pathog
2019
31649328
ZBTB32 restrains antibody responses to murine cytomegalovirus infections, but not other repetitive challenges.
Sci Rep
2019
30559127
Viral MHCI inhibition evades tissue-resident memory T cell formation and responses.
Journal of Experimental Medicine
2019
30617115
Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease.
J Immunol
2019
1 - 50 of 98
Column Actions
Search
Recommended Authors
Collaborators
Michael S Diamond
Washington University School of Medicine
Co-authored papers
16
Rita E Chen
Co-authored papers
11
Mehul S Suthar
Co-authored papers
8
Laura A VanBlargan
Washington University School of Medicine
Co-authored papers
7
Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers
7
James E Crowe
Vanderbilt University Medical Center
Co-authored papers
7
Pavlo Gilchuk
Vanderbilt University Medical Center
Co-authored papers
7
Scott A Handley
Washington University School of Medicine
Co-authored papers
6
Anshu P Gounder
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
5
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers
4
Michael J Holtzman
Co-authored papers
4
Dan H Barouch
Co-authored papers
4
Maxim N Artyomov
Co-authored papers
4
Patrizia Caposio
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
3
Deborah J Lenschow
Co-authored papers
3
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers
3
Wesley I Sundquist
University of Utah School of Medicine
Co-authored papers
3
Nels C Elde
University of Utah School of Medicine
Co-authored papers
3
Andrew D Yurochko
Louisiana State University
Co-authored papers
3
Rolf Renne
Co-authored papers
3
Adam S Lauring
University of Michigan ann arbor
Co-authored papers
3
Nicholas S Heaton
Duke University School of Medicine
Co-authored papers
3
Meaghan H Hancock
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers
3
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers
3
Charles M Rice
Rockefeller University
Co-authored papers
3
Matthew D Weitzman
The Children's Hospital of Philadelphia
Co-authored papers
3
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers
3
Arturo Casadevall
Johns Hopkins Bloomberg School of Public Health
Co-authored papers
3
Andrew Pekosz
Co-authored papers
3
1 - 30